Skip to main content
. 2020 Feb 17;10(2):109. doi: 10.3390/diagnostics10020109

Figure 3.

Figure 3

Positive distribution of Capilia Adeno Eye® and Allerwatch®. Of the 60 patients enrolled, 55 (91.7%) had positive results on at least one test, and one patient tested positive on both tests.